Introduction
Ginkgo biloba is an ancient Chinese tree, appeared more than 250 million years ago, and the only surviving member of Ginkgoacea family [Schmid, 1997] . Ginkgo biloba was used as herbal remedy for many centuries in China, and now its extracts are one of the most widely used herbal products in the world, especially in the United States and in Europe [Blumenthal, 2000; Mahadevan & Park, 2008] . Ginkgo biloba extract is considered an alternative medicine for the treatment and/or the prevention of different pathologies and in some cases it could be suggested to be used as complementary of the mainstream medicine [Ernst, 2000] . In fact, over the past decades, there was a steady growth trend in the use of these alternative treatments. In particular, concentrated and partially purified products, containing Ginkgo biloba active constituents, have been marketed widely in the world for the treatment of cognitive deficits and other age-associated impairments [Kanowski et al., 1996; Le Bars et al., 1997] . Furthermore, it has been used as therapeutic compound for many other chronic and acute forms of diseases such as cardiovascular and bronchial pathologies [Diamond et al., 2000] . In view of the large market as well as the keen interest in the use and rediscovery of these herbal products throughout the world, the quality control of Ginkgo biloba extracts becomes necessary, in order to guarantee their clinical efficacy and safety. Therefore, it is important to monitor simultaneously the bioactive constituents present in Ginkgo biloba extracts, optimizing the analysis time and reducing costs. In fact, in the recent years, numerous groups reported in literature different analytical methods, using various chromatographic conditions and spectophotometric technologies, to create quick, accurate and applicable analytical approaches for the identification and the chemical structure characterization of Ginkgo biloba constituents. Ginkgo biloba extracts contain a large number of representative constituents such as terpenoids, polyphenols, allyl phenol, organic acids, carbohydrates, fatty acids and lipids, inorganic salts and amino acids. However, the pharmacological activity of Ginkgo biloba
The investigations of neuroprotective effects of Ginkgo biloba have used its standardized extract. The extract standardized contains about 24% flavonoid glycosides and 6% terpene lactone. Specifically Ginkgo biloba extract (GBE) is described to have different biological effects. For example, several authors reported that GBE may be a molecular target of amyloid precursor protein (APP) [Luo et al., 2002; Agustin et al., 2009; Jin et al., 2009] and it determined beneficial effects on brain function. Other authors investigated the action of GBE on oxidative damage [Bridi et al., 2001; Naik et al., 2006; Sener et al., 2007] , specifically in relation to ischemia/reperfusion [Urikova et al., 2006; Domorakova et al., 2009] . In addition, it is reported that GBE protects against mitochondrial dysfunction in platelets and hippocampi [Shi et al., 2010a; Shi et al., 2010b] . Ginkgo biloba extract it was also reported to have a positive effect on memory in healthy animals [Gong et al., 2006; Yamamoto et al., 2007; Blecharz-Klin et al., 2009] and humans [Kennedy et al., 2007] . Of course a number of authors concern the effect of GBE on typical neuro-degeneration diseases, such as Alzheimer [Agustin et al., 2009; Luo, 2006; Ahlemeyer & Krieglstein, 2003; Luo, 2001] and Parkinson [Beal, 2003; Kim et al., 2004; Ahmad et al., 2005; Chen et al., 2007; Rojas et al., 2008] . Regarding the flavonoid fraction of GBE only few studies have been performed and they concern prevention of membrane damage caused by free radicals. In particular, flavonoid fraction protects cultures of neurons against oxidative stress due to hydrogen peroxide and iron sulfate [Sloley et al., 2000] , as well as neural tissue against cerebral ischemia lesion [ Dajas et al., 2003] . Moreover, it was described that flavonoid fraction inhibited sodium nitroprusside-induced death in primary hippocampal cultures of rat [Saija et al., 1995] , and the authors suggested that flavone glycosides, as radical scavengers, block the formation of peroxynitrite as a product of NO and superoxide anion reaction. Concerning the terpene-lactones, studies mainly regard bilobalide. In vitro and ex vivo investigations indicate that bilobalide has multiple actions, such as preservation of mitochondrial ATP synthesis [Janssens et al., 1995] , inhibition of apoptotic damage [Ahlemeyer et al., 1999] , suppression of hypoxia-induced membrane deterioration [Klein et al., 1997] and increasing the expression of the mitochondrial DNA-encoded COX III [Chandrasekaran et al., 2001] . Specifically, the sesquiterpene reduces the edema formation in hippocampal slices exposed to N-methyl-D-aspartate (NMDA) , or obtained by oxygen-glucose deprivation (OGD) [Mdzinarishvii et al., 2007] . The neuroprotective effect of bilobalide is partially correlated to its GABAergic antagonism, but it doesn't fully explain the bilobalide's action . More recently, it has been reported that glycine, at 10-100 mM level, contrasts the effect of bilobalide. In particular, bilobalide reduces the release of glycine during ischemia but it does not interact with glycine receptors [Kiewert et al., 2008] . Because bilobalide is instable, it has been prepared a stable derivative called NV-31. This modified compound resulted to reduce by 50% the cellular ROS content in chick neurons submitted to serum deprivation and staurosporine-induced apoptosis [Ahlemeyer et al., 2001] . Moreover NV-31 has been reported to potentiate hippocampal neuron recombinant glycine receptor Cl channels [Lynch & Chen, 2008] . The protective effect of bilobalide against convulsion was observed by Sasaki et al. (2000) using 4-O-methylpyroxidine (MPN) for changing the levels of gamma-aminobutyric acid (GABA) and glutamic acid decarboxylase (GAD) activity in hippocampus cerebral cortex.
Finally, gingkolide B (GB) was used in neuroprotective studies. In particular, this terpenlactone reduced up-regolation of constitutive and inducible nitric oxide synthase in hyperthermic brain injury [Sharma et al., 2000] .
Structural characterization of Ginkgo biloba′s main compounds
Ginkgo biloba is characterized by the presence of numerous constituents belonging to different chemical classes, which are well investigated over the years. In fact, there are many studies that report the various groups of components present in its extracts [Van Beek, 2002; Singh et al., 2008; Van Beek & Montoro, 2009 ]. However, depending on their chemical structures, the major bioactive compounds can be classified into two groups: flavonoids and terpene lactones [Li & Fitzloff, 2002a; Li & Fitzloff, 2002b] . The flavonoids, also called phenylbenzopyrines or phenylchromones, comprise a large group of structurally related compounds, characterized by the presence of two aromatic rings and a heterocyclic ring with one oxygen atom; this group include flavonol glycosides, biflavonoids, biflavones, proanthocyanidins and isoflavonoids. Specifically, the flavonoids most commonly present in Ginkgo biloba extracts are the flavonol glycosides, in which one or more hydroxyl group of the aglycones are bound to a carbohydrate moiety, usually via the 3 or 7 position (Fig.1) . Numerous flavonol glycosides were identified as derivatives of the phenolic aglycones (quercetin, kaempferol or isorhamnetin) that, when alone, are present in relatively low concentration [Hasler et al., 1992; Sticher, 1999] . However, the Ginkgo biloba contains also a large number of biflavonoids, which are flavonoid-flavonoid dimers connected by a C-O-C or C-C bond. Terpene lactones include 20-carbon diterpene lactone derivatives (ginkgolides) and a 15-carbon sesquiterpene (bilobalide). These compounds are the unique natural products to possess a tert-butil group in their structure [Van Beek, 2005) (Fig.2) . In particular, ginkgolides contain a rigid carbon skeleton consisting of six fused 5-membered carbocyclic rings, that is, a spiro [4.4] nonane carbocyclin ring, three lactones and a tetraydrofuran. On the contrary bilobalide has a more flexible structure containing only 5-membered rings [Nakanish et al., 1971] . By far the terpene lactones received a great attention for the chemical uniqueness, due to their cage like structure. Ginkgolide A, B, C and M were isolated for the fist time from Ginkgo biloba root bark and described by Furukawa in 1932 Furukawa in (1932 , and only later, ginkgolides A, B and C were reported to be present in the leaves too. Ginkgolide J was identified, by Weings et al. in 1987 Weings et al. in (1987 , as a minor constituent present in the leaves of Ginkgo biloba. In addition, Wang et al. (2001) reported the identification of other two ginkgolides (K and L) containing a further double bond. In fact, Yuan et al. (2008) recently described ginkgolide K as the dehydrated form of ginkgolide B. Similarly, ginkgolide L should derived from the dehydratation of ginkgolide A, although this hypothesis is not confirmed in literature. A thorough mass spectrometric investigation of this class of compounds is very important for their identification and characterization. The fragmentation pathway of bilobalide observed in our laboratory is shown in Fig.3 . It was based on data obtained by means of LC-MS/MS analysis with an APCI source and an ion trap analyzer (ITMS), in negative ion mode. These results are in good agreement with those observed by Sun et al. (2005) using an electrospray interface. Instead, the fragmentation of bilobalide obtained by LC-ESI-MS/MS using a triple quadrupole (QqQ) analyzer, shows differences related to the relative abundances of the fragmented ions. Specifically, the most abundant fragments are m/z 163 and 251 from QqQ and ITMS, respectively. Table 1 reports the fragmentated bilobalide ions obtained by ion trap and triple quadrupole. In particular, ion product at m/z 325 is due to the loss of a ter-butyl and a hydroxyl group, while fragmentation at m/z 163 is related to the loss of two carbon dioxide molecules. 
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Analytical methods for quality control of Ginkgo biloba extracts
Chemical fingerprint analysis represents a comprehensive approach for the quality assessment purpose of traditional Chinese herbs. In fact, most herbal medicines are complex mixtures whose therapeutic effect is often attributed to the cumulative effects of many components. For this reason, it is important to achieve an overall view of all the components present in the extracts to evaluate the quality of the plant products. Moreover, it is necessary and important to develop a reliable and applicable quality control method for the constituents present in most herbal extracts. To this end, different analytical methods are proposed for the quality and the stability evaluation of herbal medicines. As described above, for the analysis of the flavonoids and terpene lactones, the main bioactive compounds present in Ginkgo biloba extracts, the scientific literature report a lot of methods. The great number of these methods is based on high-performance liquid chromatography (HPLC) coupled to UV [Pietta et al., 1990; Pietta et al., 1992; Hasler, et al., 1992] , refractive index (RI) [Van Beek et al., 1991; Chen et al., 1998; Wang & Ju, 2000] , or ELSD ] detection and gas chromatography (GC) combined to flame ionisation (FID) [Huch & Staba, 1993; Van Beek, 2002; Yang et al., 2002] or mass spectrometry (MS) [Chauret et al., 1991; Deng & Zito, 2003 ] detection. High-performance liquid chromatography coupled to the ultra-violet detection (HPLC-UV) is the technique of choice for the fingerprinting analysis of the total flavonoids of Ginkgo biloba L. extracts [Hasler et al., 1992] , while it presents several limitations for the qualitative and quantitative determination of terpenes, due to their low UV absorption and the impurities present in the complex matrix of Ginkgo biloba L. extracts. However, Pietta et al. (1990; described a new procedure for the preparation of samples that, using HPLC combined to UV detector, permits the identification of terpene compounds of Ginkgo biloba L. extracts. In particular, in the study proposed by Pietta et al. in 1990 was developed an efficient method for the purification of terpene compounds in Ginkgo biloba L. extracts based on the separation of the ginkgolides fractions by means of prepacked alumina columns. The resulting cleaned samples were separated by isocratic elution on Microsorb C18 columns (analytical: 100 x 4.6 mm i.d., 3µm; Rainin Instrument Co., Woburn, MA, USA -semipreparative: 250 x 10 mm i.d., 5 µm; Biolab Instrument) using 10% isopropanol and analyzed with an UV photodiode detector. These results show that, combining a new sample purification process together with the optimization of the chromatographic conditions, it is possible to obtain a simple method suitable for the determination of bilobalide, ginkgolide A, B and C in Ginkgo biloba L. extracts. Several investigators instead applied refractive index (RI) as an alternative detection method [Van Beek et al., 1991; Chen et al., 1998; Wang & Ju, 2000] . As an example, Wang and Ju (2000) developed a rapid analytical method that, using HPLC on a C18 column with methanol-water-orthophosphoric acid as eluents combined to refractive index (RI) detector, permits the quantification of terpene lactones (bilobalide and ginkgolide A, B, C, J) in Ginkgo biloba L. extracts in only 20 min of analysis time. This method resulted to be more suitable and was employed with considerable success, although the sensitivity and the baseline stability still remain a problem. On the contrary, evaporative light scattering detection (ELSD) seems to solve the problems related to the baseline stability and permits to reach higher sensitivity, requiring small solvent consumption. So, even if it is a non-selective detector, this technique has gained in popularity over the last decades, due to its capacity to detect the number and size of nonvolatile compounds. In fact, several papers reported the application of HPLC with ELSD detector for the routine determination of ginkgolides and bilobalide [Li & Fitzloff, 2002b; Tang et al., 2003; Dubber & Kanfer, 2006] . As an example, Tang et al. (2003) , applied RP-HPLC-ELSD method for the quantitation analysis of terpene lactones in Ginkgo biloba extracts. These authors by means of a Dinamic C18 column, using methanol and water under isocratic conditions as mobile phase (33:67, v/v), obtained the separation of five terpene lactones in 40 min of analysis time (bilobalide and ginkgolide A, B, C, J). This method represented a big advantage in terms of selectivity and precision; however the narrow linearity intervals (from 100 to 800µg/ml) produced through ELSD response represent the major inconvenience of such kind of detectors. Another excellent separation technique for terpene lactones is represented by gaschromatography coupled to flame ionization detection (GC-FID) [Huch & Staba, 1993; Lang & Wai, 1999; Van Beek, 2002; Yang et al., 2002] which is very reliable for the sensitivity and reproducibility. However, the sensitivity and selectivity of this separative technique could be further increased by the coupling with mass spectrometer detectors (MS) [Chauret et al., 1991; Biber & Koch, 1999; Deng & Zito, 2003 ]. Nevertheless GC-based methods require complicated and time-consuming sample preparation steps and compound derivatization. In the recent years, these problems are solved with the development of several mass spectrometry instruments and taking advantage of the combination of these ones with HPLC separation systems. In fact, in literature are reported many works in which different MS techniques were coupled to HPLC for analysing Ginkgo biloba extracts. In particular, different investigators developed HPLC methods combined to MS detection, using a thermospray interface (TSP) (Pietta et al., 1994; Caponovo et al., 1995) . Briefly, Pietta et al. (1994) , applied high-performance liquid chromatography interfaced with a thermospray ion source mass spectrometer (LC-TSP/MS) for the identification of various flavonol glycosides from Ginkgo biloba. While, Caponovo et al. in 1995, employed LC-TSP/MS analytical techniques for the rapid detection of ginkgo terpene lactones. LC-TPS/MS method is not very precise due to variability and poor stability of the TSP interface. On the contrary, the discovery of the API (atmospheric pressure ionization) interfaces and in particular of electrospray ionisation sources (ESI) allowed a soft ionization and a stable combination between HPLC separation and MS detection. As reported by Mauri et al. (1999) , the method based on liquid chromatography coupled with electrospray mass spectrometry (LC-ESI-MS) is specific, reproducible, rapid and permits quantitative analyses of terpenoids in Ginkgo biloba extracts. In particular LC-ESI-MS method permitted the monitory of terpene lactones in Ginkgo biloba extracts by means of quadrupole instrument (positive mode) coupled to a C18 columns and 20 min of analysis time in isocratic separation [Mauri et al., 1999] . Similar results were obtained by Jensen et al. (2002) using a triple quadrupole equipped with an atmospheric pressure chemical ionization (APCI) interface in the negative ion mode and a methanol gradient. For increasing the sensitivity quadrupole needs selectively detection of single ion monitoring (SIM).
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However, in this way, increasing the number of selected ions monitored, the sensitivity decreases and it is not possible to monitor unexpected ions. These problems were solved with the introduction of ion trap mass spectrometer (ITMS). In fact ITMS present the same sensitivity in full scan and SIM modes. Ding et al. (2008a) characterized the flavonoid and terpene compounds of Ginkgo biloba products by using a C18 capillary column coupled to ion trap MS. The use of the negative ion mode combined to the data depending scan for MS/MS acquisition lead to the characterization of more than 70 components from the Ginkgo biloba in 140 min of analysis time. As another example Chen et al. (2005) used a 28 min HPLC separation, based on a C18 analytical column, coupled to sonic spray ionization source (SSI) and a mass spectrometer equipped with a ion trap analyzer for characterizing terpene lactones constituents from Ginkgo biloba extracts in positive ion mode. On the other hand, Mauri et al. (2001) used liquid chromatography/atmospheric pressure chemical ionization for coupling HPLC with ion trap mass spectrometry (LC/APCI-IT-MS) to study the pharmacokinetics of terpene lactones in human. In particular, in this study chromatographic separation was achieved in less than 8 min and calibration curve was linear over a concentration range of 5-2000 ng/ml. In addition to the ion trap analyzer, Ding et al. (2008b) employed a quadrupole time-offlight (QTOF) mass spectrometer for characterizing terpene lactones (bilobalide and ginkgolide A, B, C,) in Ginkgo biloba L. extracts [Ding et al., 2008b] . Specifically, the authors used both analyzers to obtain two specific goals: ion trap MS for the characterization of the terpene fragmentation pathways and QTOF for the estimation of fragment ion mass accuracy (3-5 ppm) and the confirmation of the structural identification. More recently, in our laboratory, the accurate mass measurement of the Ginkgo biloba terpene lactones was performed by means of the Exactive (Thermo Electron Corporation, San Josè, CA, USA) a non -hybrid mass spectrometer based on the Orbitrap technology. This instrument, equipped with a nanoelectrospray ion source, allows the acquisition of accurate mass data together with the improvement of sensitivity. The full scan spectra were acquired at a resolution setting of 100,000 in an infusion experiment calibration (i.e. no lock masses were used) and a high dynamic range. In particular, for all the terpene lactone ions showed in Fig. 4 it was possible to achieve narrow peak widths with a mass accuracy and a resolving power of around 0,2 ppm and 8 x 10 5 , respectively. High resolution, accurate mass measurement together with high dynamic range are required for unequivocal characterization of mixtures even in the absence of precursor ion mass selection. However, if it is needed, additional informations can be provided by high resolution/ high mass accuracy MS/MS experiments in an "all ion fragmentation" mode. In fact, the Exactive mass spectrometer allows high efficiency "all ion fragmentation" experiments by means of Higher energy Collision induced Dissociation (HCD) [Olsen et al., 2007] . All these performance characteristics make this mass spectrometer well suited for discovery analyses, screening applications, quantitative estimation and elemental composition determination, solving the limitation of the ion trap technology and representing a good alternative to the ion trap based hybrid instruments.
Pharmacokinetic analysis
Pharmacokinetic and metabolic studies of Ginkgo biloba extracts concern the investigations of the main bioactive compounds, flavonoids and terpene-lactones. Concerning flavonoids, few metabolic studies are available. In particular, Hackett (1986) described correlation between flavonoids and their metabolites using selected standard analyzed by means of Thin-layer chromatography (TLC). Of course, TLC technique didn't permit the investigation of complex extracts. Wang et al. (2003) developed a method based on liquid chromatography coupled to UV detector (λ=380 nm) for determining kaempferol and quercetin in human urine samples after orally administrated Ginkgo biloba extract.
Other authors used LC-UV and mass spectrometry for characterizing the metabolites of flavonoids in rat [Pietta et al, 1995] and human [Pietta et al., 1997] urine samples due to administration of standardized Ginkgo biloba extract. The main metabolite resulted to be conjugates of 4-hydroxybenzoic, vanillic and 4-hydroxyhippuric acids. Recently, Ding et al. (2006) prepared an analytical method, based on ion trap mass spectrometry in negative ion mode, for assaying flavonoids in urine from volunteers after up-take with Ginkgo biloba extract. In addition, the authors monitored terpene-lactones simultaneously elution at a flowrate of 4 µL/min (LOD around 2 and 10 ng/mL for flavonoids and terpenes, respectively). This method is interesting, but requires a long gradient (> 2 hours) and standard deviation resulted higher than 10%. Concerning pharmacokinetics studies of terpene-lactones, many works are available. For example Biber [Biber & Koch; 1999] and co-workers [Furtillan et al.; used gas chromatography mass spectrometry for determining, after oral administration, the main ginkgolides in plasma from both humans [Furtillan et al., 1995] and rats [Biber & Koch, 1999] . In particular, in rats the half life of ginkgolides resulted to be around 2 h; at the contrary, in human differences were noted for ginkgolide A, ginkgolide B and bilobalide (4.5, 10.5, and 3.2 hours, respectively).
In 2001 monitor (LOD about 2 ng/mL) terpenes in plasma of volunteers after administration of two different Ginkgo biloba formulations (free and phospholipids complex formulations). When supplied in the phospholipid complex form, both Cmax and AUC (Area Under the Curve) of terpene lactones increased, suggesting that this formulation may increase their bioavailability. The same approach was extended to investigate pharmacokinetics of terpene-lactones in rats and guinea pigs after acute and chronic oral administrations [Mauri et al., 2003 ]. Other authors used APCI interface combined with a triple quadrupole analyzer for investigating the bioavailability of ginkgolides after intravenous administration to rats [Xie et al., 2008] Specifically, multiple reaction monitoring (MRM) was used and the limit of quantification resulted around 2 ng/mL. In alternative to APCI, Hua et al. (2006) proposed electrospray interface coupled to Q-arrayOctapole-Quadrupole mass analyzer (QoQ) for investigating the intragastric administration of pure ginkgolide B (0.1 ng/kg) in Beagle dogs. The authors reported a LOD around 0.1 ng/mL while Tmax and t1/2 resulted to be 0.5 h and 2.8 h, respectively. Other authors have studied the bioavailability of pure ginkgolide B after oral administration and Tmax resulted around 2 and 4 h for phytosomic and free forms, respectively [Mauri et al., 2003 ]. Concerning ginkgolide C, different authors observed a very low recovery from plasma of this terpene-lactone. This is accompanied by the increase of methylated metabolite observed in plasma of both animals and humans [Mauri et al, 2006] . All in-vivo studies of terpene-lactones from Ginkgo biloba concern plasma or urine samples. However, very recently it has been published a study about the identification of bilobalide in rat brain after single oral dose [Rossi et al., 2009] . In particular, it has been observed that bilobalide presents different profiles in brain and plasma samples. In fact, in plasma the bilobalide levels increase with the administered dose; while the brain levels increase for dose up to 10 mg/kg; and decrease for higher doses. These results support the studies that described the positive cognitive efforts on brain due to Ginkgo biloba extracts (Lee et al., 2002; Kennedy et al., 2007) . Moreover the absorption of bilobalide could be explained by a specific mechanism of transport and by an inhibition effect due to an overloading of transporter after its administration at high doses.
Conclusion
Ginkgo biloba contains mainly two types of constituents, the flavonoids and terpene lactones, which together have been proven to be responsible of the polyvalent activities of Ginkgo biloba herbal and Ginkgo biloba-containing preparations. In fact, for many centuries Ginkgo biloba was used for the treatment of several pathologies, but in recent years its interest increased in relation to the neuroprotective activities ascribed to terpene lactones. To this end, the development of many analytical technologies improved fingerprinting authentication and quantitative determination of target analytes, as well as the pharmacokinetic and pharmacodynamic studies on the active components of Ginkgo biloba and its finished products. This is because of selectivity and specificity achieved by both the chromatographic and mass spectrometry detection systems. In particular, LC-MS approach appeared to be the method of choice for the measurement of target analytes in biological samples. In fact, the separation efficiency and fastness of the new HPLC systems combined to the high resolution and accurate measurements of the recent mass spectrometry detectors permit an unequivocal characterization of bioactive compounds from Ginkgo biloba extracts. These analytical tools will be very important for elucidating the transport and pharmacological in vivo mechanisms of terpene lactones and flavonoids.
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